Insulet | PODD - Action





Action Changement Date
Abbott USD 6.99B 501M 2026-03
Align Technology USD 212.24M 2.7M 2026-06
AtriCure USD 83.92M 2.78M 2026-06
Baxter International USD 2.26B 57M 2026-06
Becton, Dickinson and Co. USD 3.32B 41M 2026-06
Boston Scientific USD 3.24B 118M 2026-06
Cardinal Health USD 17.3B 710M 2026-06
Cooper Companies USD 876.4M 30.4M 2025-12
Dexcom USD 726.4M 32.8M 2026-06
Edwards Lifesciences USD 1.13B 12.2M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Globus Medical USD 810.9M 38.3M 2026-06
ICU Medical USD 607.42M 1.83M 2026-06
Inogen USD 25.08M 762K 2025-09
Insulet USD 484.8M 22.3M 2026-06
Integra LifeSciences USD 492M 3.03M 2026-06
J&J USD 15.14B 561M 2026-06
Medtronic USD 5.95B 358M 2026-03
Merit Medical Systems USD 374.11M 21.73M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Solventum Corp USD 1.04B 49M 2026-06
Stryker USD 5.52B 102M 2026-06
Tandem Diabetes Care USD 135.11M 8.71M 2026-06
Teleflex USD 351.91M 28.95M 2026-06
West Pharmaceutical Services USD 447.4M 5.2M 2026-06
Zimmer Biomet Holdings USD 2.27B 23.5M 2026-06